Livet Skal Leves (A Life to Live)
- Conditions
- Heart Defects, Congenital
- Registration Number
- NCT03957512
- Lead Sponsor
- Oslo University Hospital
- Brief Summary
The overall objective of this project is to optimize the use of diagnostic methods and follow-up programs in infants with congenital heart defects (CHDs) in order to reduce death and complications
- Detailed Description
The project is designed as retrospective cohort study based on nationwide registry data of children born 2004-16. The project group has extensive experience of similar research, and includes representatives from different fields and levels of health care.
The results will provide a solid fundament for improvement of today's clinical practice, including development of knowledge-based routines in neonatal medicine and planning of health care services. Implementation is given particular attention, and will be managed in an interdisciplinary setting. The project will be of major relevance for the patients and their families as well as medical professionals at all levels of health care.
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 3000
- Fetuses with severe CHDs who were identified by antenatal ultrasound screening, and where the pregnancy was terminated
- Children with severe congenital heart defects born in Norway 2004-18
- Lack of parental consent
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Mortality 0-2 years All deaths including prenatal termination of pregnancy
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (1)
Oslo University Hospital
🇳🇴Oslo, Norway